RAMM Pharma Price To Book vs. Revenue
Based on the key profitability measurements obtained from RAMM Pharma's financial statements, RAMM Pharma Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess RAMM Pharma's ability to earn profits and add value for shareholders.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please note, there is a significant difference between RAMM Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if RAMM Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAMM Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For RAMM Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of RAMM Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well RAMM Pharma Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between RAMM Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of RAMM Pharma Corp over time as well as its relative position and ranking within its peers.
RAMM |
RAMM Pharma Corp Revenue vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining RAMM Pharma's current stock value. Our valuation model uses many indicators to compare RAMM Pharma value to that of its competitors to determine the firm's financial worth. RAMM Pharma Corp is rated fifth in price to book category among its peers. It is currently regarded number one company in revenue category among its peers totaling about 23,149,876 of Revenue per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RAMM Pharma's earnings, one of the primary drivers of an investment's value.RAMM Revenue vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
RAMM Pharma |
| = | 0.18 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
RAMM Pharma |
| = | 4.12 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
RAMM Revenue vs Competition
RAMM Pharma Corp is currently regarded number one company in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 8.92 Million. RAMM Pharma totals roughly 4.12 Million in revenue claiming about 46% of equities under Drug Manufacturers—Specialty & Generic industry.
RAMM Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in RAMM Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, RAMM Pharma will eventually generate negative long term returns. The profitability progress is the general direction of RAMM Pharma's change in net profit over the period of time. It can combine multiple indicators of RAMM Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Ramm Pharma is traded on OTC Exchange in the United States.
RAMM Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on RAMM Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of RAMM Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the RAMM Pharma's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in RAMM Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Use Investing Themes to Complement your RAMM Pharma position
In addition to having RAMM Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |